InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-26)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

US US6,790 companies

US-Listed Companies

Regulator: SEC (Form 4).

Talkspace, Inc.

Santé & Pharma

Talos Energy INC.

Énergie · 2.7bn

Tandem Diabetes Care INC

Santé & Pharma · 1.5bn

Tandy Leather Factory INC

Distribution & Commerce · 19m

Tanger Factory Outlet Centers, INC

Immobilier · 3.8bn

Luxe & Mode · 26bn

Targa Resources Corp.

Énergie · 40bn

Targa Resources Corp.

Énergie · 58bn

Target Hospitality Corp.

Tourisme & Hôtellerie · 1.9bn

Target Hospitality Corp.

Tourisme & Hôtellerie · 799m

Taronis Fuels, Inc.

← PreviousPage 121 of 136Next →

Énergie

Tarsus Pharmaceuticals, Inc.

Santé & Pharma · 2.7bn

Services aux entreprises · 1.1bn

Tattooed Chef, Inc.

Agroalimentaire

Tauriga Sciences, INC.

Santé & Pharma

Taylor Devices INC

Industrie · 166m

Taylor Devices, INC.

Industrie · 166m

Taylor Morrison Home Corp

Construction & BTP · 5.1bn

Taysha Gene Therapies, Inc.

Santé & Pharma · 1.7bn

Taysha Gene Therapies, Inc.

Santé & Pharma · 1.7bn

Teads Holding Co.

Médias & Communication · 92m

Médias & Communication · 375m

Technical Communications CORP

Technologie · 185

Technology & Telecommunication Acquisition Corp

Techpoint, Inc.

Techprecision CORP

Industrie · 22m

Tecnoglass Inc.

Chimie & Matériaux · 1.7bn

Tectonic Financial, Inc.

Finance & Banque

Tectonic Therapeutic, Inc.

Santé & Pharma · 526m

Immobilier · 424m

Tekkorp Digital Acquisition Corp.

Tekla Healthcare Investors

Finance & Banque · 1.1bn

Tekla Healthcare Opportunities Fund

Santé & Pharma · 715m

Tekla Life Sciences Investors

Santé & Pharma · 448m

Tekla World Healthcare Fund

Finance & Banque · 510m

Teladoc Health, Inc.

Santé & Pharma · 1.2bn

Teledyne Technologies INC

Défense & Aérospatial · 24bn

Telephone & Data Systems INC

Autres · 4.7bn

Santé & Pharma

Telix Pharmaceuticals Ltd

Santé & Pharma · 2.5bn

Tempest Therapeutics, Inc.

Santé & Pharma · 27m

Templeton Global Income Fund

Finance & Banque

Tempur Sealy International, INC.

Distribution & Commerce

Tempus AI, Inc.

Santé & Pharma · 11bn

Tenable Holdings, Inc.

Technologie · 2.4bn

Tenax Therapeutics, INC.

Santé & Pharma · 114m

Tenaya Therapeutics, Inc.

Santé & Pharma · 154m

Tenet Healthcare CORP

Santé & Pharma · 17bn

Technologie · 2.8bn